» Articles » PMID: 33169017

Rapid Pathogen Detection by Metagenomic Next-generation Sequencing of Infected Body Fluids

Abstract

We developed a metagenomic next-generation sequencing (mNGS) test using cell-free DNA from body fluids to identify pathogens. The performance of mNGS testing of 182 body fluids from 160 patients with acute illness was evaluated using two sequencing platforms in comparison to microbiological testing using culture, 16S bacterial PCR and/or 28S-internal transcribed ribosomal gene spacer (28S-ITS) fungal PCR. Test sensitivity and specificity of detection were 79 and 91% for bacteria and 91 and 89% for fungi, respectively, by Illumina sequencing; and 75 and 81% for bacteria and 91 and 100% for fungi, respectively, by nanopore sequencing. In a case series of 12 patients with culture/PCR-negative body fluids but for whom an infectious diagnosis was ultimately established, seven (58%) were mNGS positive. Real-time computational analysis enabled pathogen identification by nanopore sequencing in a median 50-min sequencing and 6-h sample-to-answer time. Rapid mNGS testing is a promising tool for diagnosis of unknown infections from body fluids.

Citing Articles

Talaromyces Marneffei infections in five human immunodeficiency virus-negative patients with the history of predation on wild bamboo rats (Rhizomys spp) - a case series.

Cao L, Sun Y, Zhou Z, Pan X BMC Infect Dis. 2025; 25(1):340.

PMID: 40069619 PMC: 11895350. DOI: 10.1186/s12879-025-10713-z.


Clinical utility of nanopore-targeted sequencing for diagnosing and treating pulmonary infectious diseases from bronchoalveolar lavage fluid.

Li G, Sun H, Ye Y, Chen L, Zhang W, Yu S Front Cell Infect Microbiol. 2025; 15:1469440.

PMID: 40046190 PMC: 11879936. DOI: 10.3389/fcimb.2025.1469440.


Effect of Interpretation of Positive Metagenomic Next-Generation Sequencing Reports on the Infection Diagnosis in Patients With Hematological Disorders.

Xu C, Shen Y, Chen S, Liu T, Chen X, Yu Y Open Forum Infect Dis. 2025; 12(2):ofaf076.

PMID: 40041441 PMC: 11878555. DOI: 10.1093/ofid/ofaf076.


Cell-free DNA next-generation sequencing for Mycobacterium tuberculosis obtained from plasma of children with active tuberculosis.

Quan S, Tian X, Sun Y, Qi H, Jiao W, Sun B BMC Pediatr. 2025; 25(1):164.

PMID: 40033239 PMC: 11874688. DOI: 10.1186/s12887-025-05526-7.


Cell-Free Nucleic Acids for Early Diagnosis of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

Zhang X, Cai Y, Sit B, Jian R, Malki Y, Zhang Y Int J Mol Sci. 2025; 26(4).

PMID: 40003998 PMC: 11855205. DOI: 10.3390/ijms26041530.


References
1.
Messacar K, Parker S, Todd J, Dominguez S . Implementation of Rapid Molecular Infectious Disease Diagnostics: the Role of Diagnostic and Antimicrobial Stewardship. J Clin Microbiol. 2016; 55(3):715-723. PMC: 5328439. DOI: 10.1128/JCM.02264-16. View

2.
Rea B, Maisel J, Glaser L, Alby K . Identification of Clinically Relevant Mycobacterial Species After Extended Incubation Times in the BACTEC MGIT System. Am J Clin Pathol. 2018; 151(1):63-67. DOI: 10.1093/ajcp/aqy086. View

3.
Janda J, Abbott S . 16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls. J Clin Microbiol. 2007; 45(9):2761-4. PMC: 2045242. DOI: 10.1128/JCM.01228-07. View

4.
Petti C, Polage C, Schreckenberger P . The role of 16S rRNA gene sequencing in identification of microorganisms misidentified by conventional methods. J Clin Microbiol. 2005; 43(12):6123-5. PMC: 1317215. DOI: 10.1128/JCM.43.12.6123-6125.2005. View

5.
Reuwer A, van den Bijllaardt W, Murk J, Buiting A, Verweij J . Added diagnostic value of broad-range 16S PCR on periprosthetic tissue and clinical specimens from other normally sterile body sites. J Appl Microbiol. 2018; 126(2):661-666. DOI: 10.1111/jam.14156. View